New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer
July 24, 2026
July 24, 2026
NEW YORK, July 24 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer
*
Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder cancer live longer while reducing the risk that their cancer will return after surgery, ac . . .
* * *
New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer
*
Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder cancer live longer while reducing the risk that their cancer will return after surgery, ac . . .